Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin SR for Postherpetic Neuralgia
NCT02868801Phase 3Unknown
- Sponsor
- Hengrui
- Start
- Mar 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in postherpetic neuralgia (PHN) (4 arms), sponsored by Hengrui. Primary endpoint: Number of Responders at 15 weeks. Status: unknown.
02
Drugs
pregabalin
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT02868801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02868801.